Michael Msall to Bronchopulmonary Dysplasia
This is a "connection" page, showing publications Michael Msall has written about Bronchopulmonary Dysplasia.
Connection Strength
1.003
-
The HYdrocortisone for Bronchopulmonary Dysplasia Respiratory and Developmental (HYBRiD) outcomes study: protocol for a longitudinal cohort study. BMC Pediatr. 2024 Nov 14; 24(1):737.
Score: 0.219
-
Optimizing trajectories of social adaptive competencies after extreme prematurity during the first 1000 days. Semin Fetal Neonatal Med. 2024 02; 29(1):101531.
Score: 0.210
-
Smartphone application links severity of retinopathy of prematurity to early motor behavior in a cohort of high-risk preterm infants. J AAPOS. 2023 02; 27(1):12.e1-12.e7.
Score: 0.192
-
Prospective Risk Stratification Identifies Healthcare Utilization Associated with Home Oxygen Therapy for Infants with Bronchopulmonary Dysplasia. J Pediatr. 2022 12; 251:105-112.e1.
Score: 0.187
-
Cognitive Development and Quality of Life Associated With BPD in 10-Year-Olds Born Preterm. Pediatrics. 2018 06; 141(6).
Score: 0.139
-
Count of Neonatal Morbidities Predicts Outcomes at Age 10 and 15 Years in Infants Born Extremely Preterm. J Pediatr. 2025 Oct; 285:114709.
Score: 0.057